Evidence map›Paper›PMID 40206724›Full record

ReviewMayo Clinic proceedings. Digital health2023

Assessment of Performance, Interpretability, and Explainability in Artificial Intelligence-Based Health Technologies: What Healthcare Stakeholders Need to Know.

Line Farah, Juliette M Murris, Isabelle Borget, Agathe Guilloux, Nicolas M Martelli, Sandrine I M Katsahian

Abstract readReview
In one paragraph

Review in Mayo Clinic proceedings. Digital health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. The Right to Explanation in AI: In a Lonely Place.Journal of medical Internet research · 2025
    Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Health technology assessment framework for artificial intelligence-based technologies.International journal of technology assessment in health care · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Line FarahGroupe de Recherche et d'accueil en Droit et Economie de la Santé Department, University Paris-Saclay, Orsay, France.
Juliette M MurrisInserm, Centre de Recherche des Cordeliers, Sorbonne University, University Paris Cité, Paris, France.
Isabelle BorgetGroupe de Recherche et d'accueil en Droit et Economie de la Santé Department, University Paris-Saclay, Orsay, France.
Agathe GuillouxInria, Health data- and model- driven Knowledge Acquisition, PariSantéCampus, Paris, France.
Nicolas M MartelliGroupe de Recherche et d'accueil en Droit et Economie de la Santé Department, University Paris-Saclay, Orsay, France.
Sandrine I M KatsahianInserm, Centre de Recherche des Cordeliers, Sorbonne University, University Paris Cité, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review aimed to specify different concepts that are essential to the development of medical devices (MDs) with artificial intelligence (AI) (AI-based MDs) and shed light on how algorithm performance, interpretability, and explainability are key assets. First, a literature review was performed to determine the key criteria needed for a health technology assessment of AI-based MDs in the existing guidelines. Then, we analyzed the existing assessment methodologies of the different criteria selected after the literature review. The scoping review revealed that health technology assessment agencies have highlighted different criteria, with 3 important ones to reinforce confidence in AI-based MDs: performance, interpretability, and explainability. We give recommendations on how and when to evaluate performance on the basis of the model structure and available data. In addition, should interpretability and explainability be difficult to define mathematically, we describe existing ways to support their evaluation. We also provide a decision support flowchart to identify the anticipated regulatory requirements for the development and assessment of AI-based MDs. The importance of explainability and interpretability techniques in health technology assessment agencies is increasing to hold stakeholders more accountable for the decisions made by AI-based MDs. The identification of 3 main assessment criteria for AI-based MDs according to health technology assessment guidelines led us to propose a set of tools and methods to help understand how and why machine learning algorithms work as well as their predictions.

Identifiers

PMID40206724
PMCPMC11975643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.